Bayer decides to withdraw cholesterol lowering drug

BMJ. 2001 Aug 18;323(7309):359.
No abstract available

Publication types

  • News

MeSH terms

  • Aged
  • Anticholesteremic Agents / adverse effects*
  • Drug Therapy, Combination
  • Drug and Narcotic Control*
  • Gemfibrozil / adverse effects
  • Humans
  • Product Surveillance, Postmarketing
  • Pyridines / adverse effects*
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / mortality

Substances

  • Anticholesteremic Agents
  • Pyridines
  • cerivastatin
  • Gemfibrozil